-
1
-
-
84897692289
-
Measuring current and future cost of skin cancer in England
-
Vallejo-Torres L, Morris S, King JM, et al,. Measuring current and future cost of skin cancer in England. J Public Health 2014; 36: 140-8.
-
(2014)
J Public Health
, vol.36
, pp. 140-148
-
-
Vallejo-Torres, L.1
Morris, S.2
King, J.M.3
-
2
-
-
84860322847
-
A systematic review of worldwide incidence of non-melanoma skin cancer
-
Lomas A, Leonardi-Bee J, Bath-Hextall F,. A systematic review of worldwide incidence of non-melanoma skin cancer. Br J Dermatol 2012; 166: 1069-80.
-
(2012)
Br J Dermatol
, vol.166
, pp. 1069-1080
-
-
Lomas, A.1
Leonardi-Bee, J.2
Bath-Hextall, F.3
-
3
-
-
84876738410
-
Basal cell carcinoma epidemiology in the UK: The elephant in the room
-
Levell NJ, Igali L, Wright KA, Greenberg DC,. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol 2013; 38: 367-9.
-
(2013)
Clin Exp Dermatol
, vol.38
, pp. 367-369
-
-
Levell, N.J.1
Igali, L.2
Wright, K.A.3
Greenberg, D.C.4
-
4
-
-
84860324654
-
Reporting and registering non-melanoma skin cancers: A compelling public health need
-
Geller AC, Swetter SM,. Reporting and registering non-melanoma skin cancers: a compelling public health need. Br J Dermatol 2012; 166: 913-15.
-
(2012)
Br J Dermatol
, vol.166
, pp. 913-915
-
-
Geller, A.C.1
Swetter, S.M.2
-
5
-
-
0027010661
-
ARC monographs on the evaluation of carcinogenic risks to humans. Solar and ultraviolet radiation
-
Anon
-
Anon. ARC monographs on the evaluation of carcinogenic risks to humans. Solar and ultraviolet radiation. IARC Monogr Eval Carcinog Risks Hum 1992; 55: 1-316.
-
(1992)
IARC Monogr Eval Carcinog Risks Hum
, vol.55
, pp. 1-316
-
-
-
6
-
-
72949122123
-
Interventions to promote cancer awareness and early presentation: A systematic review
-
Austocker J, Bankhead C, Forbes LJ, et al,. Interventions to promote cancer awareness and early presentation: a systematic review. Br J Cancer 2009; 101: S31-9.
-
(2009)
Br J Cancer
, vol.101
, pp. S31-S39
-
-
Austocker, J.1
Bankhead, C.2
Forbes, L.J.3
-
7
-
-
84890142663
-
Vitamin D status and ill health: A systematic review
-
Autier P, Boniol M, Pizot C, Mullie P,. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014; 2: 76-89.
-
(2014)
Lancet Diabetes Endocrinol
, vol.2
, pp. 76-89
-
-
Autier, P.1
Boniol, M.2
Pizot, C.3
Mullie, P.4
-
8
-
-
49449089153
-
Sun exposure and vitamin D sufficiency
-
Gilchrest BA,. Sun exposure and vitamin D sufficiency. Am J Clin Nutr 2008; 88: 570S-577S.
-
(2008)
Am J Clin Nutr
, vol.88
, pp. 570S-577S
-
-
Gilchrest, B.A.1
-
9
-
-
84881159154
-
Vitamin D and melanoma
-
Field S, Davies J, Bishop DT, Newton-Bishop JA,. Vitamin D and melanoma. Dermatoendocrinol 2013; 5: 121-9.
-
(2013)
Dermatoendocrinol
, vol.5
, pp. 121-129
-
-
Field, S.1
Davies, J.2
Bishop, D.T.3
Newton-Bishop, J.A.4
-
11
-
-
84890981427
-
Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence
-
Eisemann N, Waldmann A, Geller AC, et al,. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol 2014; 134: 43-50.
-
(2014)
J Invest Dermatol
, vol.134
, pp. 43-50
-
-
Eisemann, N.1
Waldmann, A.2
Geller, A.C.3
-
12
-
-
0035860141
-
The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study
-
Melia J, Moss S, Coleman D, et al,. The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study. Br J Cancer 2001; 85: 803-7.
-
(2001)
Br J Cancer
, vol.85
, pp. 803-807
-
-
Melia, J.1
Moss, S.2
Coleman, D.3
-
13
-
-
84865029520
-
Euromelanoma: A dermatology led campaign against non-melanoma skin cancer and cutaneous melanoma. Past, present, future
-
Stratigos AJ, Forsea AM, van der Leest RJ, et al,. Euromelanoma: a dermatology led campaign against non-melanoma skin cancer and cutaneous melanoma. Past, present, future. Br J Dermatol 2012; 167 (Suppl. 2): 99-104.
-
(2012)
Br J Dermatol
, vol.167
, pp. 99-104
-
-
Stratigos, A.J.1
Forsea, A.M.2
Van Der Leest, R.J.3
-
14
-
-
84871719483
-
A surveillance model for skin cancer in organ transplant recipients: A 22 year prospective study in an ethnically diverse population
-
Harwood CA, Mesher D, McGregor JM, et al,. A surveillance model for skin cancer in organ transplant recipients: a 22 year prospective study in an ethnically diverse population. Am J Transplant 2013; 13: 119-29.
-
(2013)
Am J Transplant
, vol.13
, pp. 119-129
-
-
Harwood, C.A.1
Mesher, D.2
McGregor, J.M.3
-
15
-
-
77954882666
-
Revised U.K. Guidelines for the management of cutaneous melanoma 2010
-
Marsden JR, Newton Bishop JA, Burrows L, et al,. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010; 163: 238-56.
-
(2010)
Br J Dermatol
, vol.163
, pp. 238-256
-
-
Marsden, J.R.1
Newton Bishop, J.A.2
Burrows, L.3
-
16
-
-
45749085217
-
Guidelines for the management of basal cell carcinoma
-
British Association of Dermatologists
-
Telfer NR, Colver GB, Morton CA,; British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
-
(2008)
Br J Dermatol
, vol.159
, pp. 35-48
-
-
Telfer, N.R.1
Colver, G.B.2
Morton, C.A.3
-
17
-
-
84894280560
-
British Association Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen disease) 2014
-
Morton CA, Birnie AJ, Eedy DJ,. British Association Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen disease) 2014. Br J Dermatol 2014; 170: 245-60.
-
(2014)
Br J Dermatol
, vol.170
, pp. 245-260
-
-
Morton, C.A.1
Birnie, A.J.2
Eedy, D.J.3
-
18
-
-
33846221473
-
Guidelines for the management of actinic keratosis
-
British Association of Dermatologists Therapy Guidelines and Audit Subcommittee
-
de Berker D, McGregor JM, Hughes BR,; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratosis. Br J Dermatol 2007; 156: 222-30.
-
(2007)
Br J Dermatol
, vol.156
, pp. 222-230
-
-
De Berker, D.1
McGregor, J.M.2
Hughes, B.R.3
-
19
-
-
0036178531
-
Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma
-
Motley R, Kersey P, Lawrence C, et al,. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18-25.
-
(2002)
Br J Dermatol
, vol.146
, pp. 18-25
-
-
Motley, R.1
Kersey, P.2
Lawrence, C.3
-
21
-
-
84925259103
-
-
Scottish Intercollegiate Guidelines Network (SIGN) (last accessed 18 August 2014)
-
Scottish Intercollegiate Guidelines Network (SIGN). Management of primary cutaneous squamous cell carcinoma. Available at: http://www.sign.ac.uk/guidelines/fulltext/140/index.html (last accessed 18 August 2014).
-
Management of Primary Cutaneous Squamous Cell Carcinoma
-
-
-
23
-
-
84922391333
-
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis
-
[Epub ahead of print]
-
South AP, Purdie KJ, Watt SA, et al,. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J Invest Dermatol 2014; doi: 10.1038/jid.2014.154. [Epub ahead of print]
-
(2014)
J Invest Dermatol
-
-
South, A.P.1
Purdie, K.J.2
Watt, S.A.3
-
24
-
-
52649111039
-
Basal cell carcinomas: Attack of the Hedgehog
-
Epstein EH,. Basal cell carcinomas: attack of the Hedgehog. Nat Rev Cancer 2008; 8: 743-54.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 743-754
-
-
Epstein, E.H.1
-
25
-
-
84861856844
-
Efficacy and safety of vismogedib in advanced basal-cell carcinoma
-
Sekulic A, Migden MR, Oro AE, et al,. Efficacy and safety of vismogedib in advanced basal-cell carcinoma. N Engl J Med 2012; 366: 2171-9.
-
(2012)
N Engl J Med
, vol.366
, pp. 2171-2179
-
-
Sekulic, A.1
Migden, M.R.2
Oro, A.E.3
-
26
-
-
84879989050
-
Systemic treatments for basal cell carcinoma (BCC): The advent of dermato-oncology in BCC
-
Ali FR, Lear JT,. Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC. Br J Dermatol 2013; 169: 53-7.
-
(2013)
Br J Dermatol
, vol.169
, pp. 53-57
-
-
Ali, F.R.1
Lear, J.T.2
-
27
-
-
18444374405
-
Mutations of the BRAF gene in human cancers
-
Davies H, Bignell GR, Cox C, et al,. Mutations of the BRAF gene in human cancers. Nature 2002; 417: 949-54.
-
(2002)
Nature
, vol.417
, pp. 949-954
-
-
Davies, H.1
Bignell, G.R.2
Cox, C.3
-
28
-
-
84857660324
-
Therapy for metastatic melanoma: The past, present and future
-
Finn L, Markovic SN, Joseph RW,. Therapy for metastatic melanoma: the past, present and future. BMC Med 2012; 10: 23.
-
(2012)
BMC Med
, vol.10
, pp. 23
-
-
Finn, L.1
Markovic, S.N.2
Joseph, R.W.3
-
29
-
-
84877912554
-
Targeted therapy and immunotherapy in advanced melanoma: An evolving paradigm
-
Khattak M, Fisher R, Turajlic S, Larkin J,. Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm. Ther Adv Med Oncol 2013; 5: 105-18.
-
(2013)
Ther Adv Med Oncol
, vol.5
, pp. 105-118
-
-
Khattak, M.1
Fisher, R.2
Turajlic, S.3
Larkin, J.4
-
30
-
-
80055092549
-
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma
-
Wang NJ, Sanborn Z, Arnett KL, et al,. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 2011; 108: 17761-6.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 17761-17766
-
-
Wang, N.J.1
Sanborn, Z.2
Arnett, K.L.3
-
31
-
-
81255137880
-
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma
-
Watt SA, Pourreyron C, Purdie K, et al,. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene 2011; 30: 4666-77.
-
(2011)
Oncogene
, vol.30
, pp. 4666-4677
-
-
Watt, S.A.1
Pourreyron, C.2
Purdie, K.3
-
32
-
-
84896696623
-
Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)
-
Cohen RB,. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC). Cancer Treat Rev 2014; 40: 567-77.
-
(2014)
Cancer Treat Rev
, vol.40
, pp. 567-577
-
-
Cohen, R.B.1
-
33
-
-
0030459428
-
Frequent clones of p53 mutated keratinocytes in normal human skin
-
Jonason AS, Kunala S, Price GJ, et al,. Frequent clones of p53 mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93: 14025-9.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 14025-14029
-
-
Jonason, A.S.1
Kunala, S.2
Price, G.J.3
-
34
-
-
77953655833
-
Photocarcinogenesis, DNA damage and gene mutations
-
De Gruijl FR, Voskamp P,. Photocarcinogenesis, DNA damage and gene mutations. Cancer Treat Res 2009; 146: 101-8.
-
(2009)
Cancer Treat Res
, vol.146
, pp. 101-108
-
-
De Gruijl, F.R.1
Voskamp, P.2
|